http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2211414-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
filingDate 1996-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be61c83f813d3dc8bcd538ec98766552
publicationDate 1996-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2211414-A1
titleOfInvention Methods for testing of therapeutic compounds
abstract The present invention is related to a method for determining the efficacy of a chemical compound for treatment of recurrent herpes virus infection, said method comprising: (a) inoculating herpes virus at a primary skin site of a non-human mammal to cause zosteriform spread of the virus through nerve cells to cause lesions at a secondary (distal) site of infection; (b) before the appearance of skin lesions at the secondary site caused by the virus, giving adoptive transfer of immunity (ATI) to the said non-human mammal, so as to provide immunity mimicking the immunological reactivity seen in a recurrent herpes virus infection in a previously infected immune host; (c) administering a chemical compound to be tested to the said non-human mammal; and (d) determining the ability of the said chemical compound to reduce the occurrence and/or severity of herpes virus-induced skin lesions at the secondary site of infection.
priorityDate 1995-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4917
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID56781
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10141
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10368
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID163112
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504591
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID56781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415040070
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10335
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3415
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID163112
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10335
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10368
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057

Total number of triples: 39.